Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Why global vaccine equity concerns could prolong the COVID-19 pandemic

By Brian Buntz | December 8, 2021

coronavirus COVID-19 Pfizer

[Photo by Fusion Medical Animation on Unsplash]

In May, the World Health Assembly set the goal of fully vaccinating 10% of each country’s population by September 30. A number of countries hit the goal, including 15 in Africa, but more than 50 didn’t.

“It’s very concerning,” said Donna Patterson, a fellow at the Wilson Center, in a recent webinar from that organization. Uneven vaccination rates threaten to extend the COVID-19 pandemic’s timelines. Some countries remain far behind the 10% goal. For example, the percentage of fully vaccinated people in Senegal is 5.6%. Burundi’s rate is near 0%. “There are other countries that are higher, mostly in North Africa, including Morocco, but that also varies,” said Patterson, who is also a professor at Delaware State University.

Vaccination rates are also lagging in regions such as the Caribbean, Latin America, and Asia.

Inconsistent travel bans are another complication to vaccine equity. The U.S., for instance, currently has a South Africa travel ban because of the Omicron variant identified there. Still, the variant is also present in the U.S. and many other countries. Researchers in the Netherlands identified the variant before two flights arrived from South Africa harboring the variant.

“Dutch researchers found this 11 days before South Africa released it,” Patterson said. “What would have happened if the Dutch researchers released it instead of the South African researchers?”

Donna Patterson

Donna Patterson

Researchers in South Africa “feel punished” for sharing the discovery of the variant with the world, Patterson said.

The act of blaming South Africa for allegedly giving rise to a variant that may have emerged elsewhere may squelch other countries from sharing information about emerging variants until they have spread throughout the world.

The reasons for the lack of vaccine equity are complex.

The tendency to attribute blame for the spread of the virus to a given country is one factor.

“Very early on, there were people who attributed [COVID-19] to China because that is where it was found and appears to have originated,” Patterson said.

Early attempts to label the virus the “Wuhan virus” or “China virus” were counterproductive and racist, Patterson said.” This virus does not care about your nationality.”

Instead of assigning blame, wealthier countries could do more to share vaccines with countries with lagging vaccination rates. “My perfect scenario is to share vaccine technology with countries that do not have access to it,” Patterson said.

While several African countries are gearing up to produce mRNA vaccines, they will not be operational until the middle of 2022 at the earliest. Until more infrastructure is in place worldwide for vaccine production, sharing more vaccine doses with the developing world remains a priority.

Ultimately, the world needs “more cooperation to contain the pandemic,” Patterson said.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

institut pasteur dakar IPD African Union vaccine investment
African Union vaccine initiative receives $45M
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
This image shows the Moderna logo.
Moderna resizes its manufacturing footprint for a post-pandemic era
This is the logo of Pfizer.
Pfizer to close Durham and Morrisville, North Carolina facilities amid major restructuring effort
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE